Literature DB >> 16208706

Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma.

Michael G Ozawa1, Virginia J Yao, Yvan H Chanthery, Patricia Troncoso, Akiyoshi Uemura, Amanda S Varner, Ian M Kasman, Renata Pasqualini, Wadih Arap, Donald M McDonald.   

Abstract

BACKGROUND: Previous studies of the TRansgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model vasculature suggest that, as tumors develop, vessels invade the glandular epithelium. However, changes in the vasculature are difficult to study in conventional thin tissue sections. The authors used a new approach to characterize morphologic and architectural changes of blood vessels and pericytes during tumor development in TRAMP mice.
METHODS: Eighty-micron cryostat sections of normal prostate and three histopathologic stages of TRAMP tumor sections, classified by epithelial cell E-cadherin immunoreactivity, were immunostained with vascular endothelial cell and pericyte receptor antibodies and evaluated by confocal microscopy.
RESULTS: In the normal mouse prostate, capillaries were most abundant in the fibromuscular tunica between the epithelium and smooth muscle of the ductules. In the prostatic intraepithelial neoplasia (PIN) stage, vessels accompanied epithelial cell protrusions into the ductule lumen but remained in the connective tissue at the basal side of the epithelium. Well differentiated tissues had extensive angiogenesis with five times the normal mean vascularity outside ductules. Vessels were of variable diameter, were associated with an increased number of pericytes, and some had endothelial sprouts. Angiogenic blood vessels from poorly differentiated adenocarcinomas were tortuous, variable in caliber, and lacked the normal hierarchy. Pericytes on these vessels had an abnormal phenotype manifested by alpha-smooth muscle actin expression and loose association with endothelial cells. Angiogenesis and loss of vascular hierarchy were also found in human prostate carcinoma.
CONCLUSIONS: Vascular abnormalities, which begin at the PIN stage and intensify in well differentiated and poorly differentiated tumors, may be useful readouts for early detection and treatment assessment in prostate carcinoma. Copyright 2005 American Cancer Society

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16208706     DOI: 10.1002/cncr.21436

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Hypoxic tumor microenvironment: Implications for cancer therapy.

Authors:  Sukanya Roy; Subhashree Kumaravel; Ankith Sharma; Camille L Duran; Kayla J Bayless; Sanjukta Chakraborty
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-27

2.  JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation.

Authors:  Elisa Boscolo; Camille L Stewart; Shoshana Greenberger; June K Wu; Jennifer T Durham; Ira M Herman; John B Mulliken; Jan Kitajewski; Joyce Bischoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-14       Impact factor: 8.311

Review 3.  Pericyte in Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Isabella Bittencourt Valle; Lauren Frenzel Schuch; Janine Mayra da Silva; Alfonso Gala-García; Ivana Márcia Alves Diniz; Alexander Birbrair; Lucas Guimarães Abreu; Tarcília Aparecida Silva
Journal:  Head Neck Pathol       Date:  2020-06-06

Review 4.  Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

5.  Pericytes on the tumor vasculature: jekyll or hyde?

Authors:  Keith D Barlow; Anne M Sanders; Shay Soker; Suleyman Ergun; Linda J Metheny-Barlow
Journal:  Cancer Microenviron       Date:  2012-03-31

6.  Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1.

Authors:  Elisa Boscolo; John B Mulliken; Joyce Bischoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

7.  Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.

Authors:  Komal Raina; Subapriya Rajamanickam; Rana P Singh; Gagan Deep; Manesh Chittezhath; Rajesh Agarwal
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

8.  Inositol hexaphosphate inhibits tumor growth, vascularity, and metabolism in TRAMP mice: a multiparametric magnetic resonance study.

Authors:  Komal Raina; Kameswaran Ravichandran; Subapriya Rajamanickam; Kendra M Huber; Natalie J Serkova; Rajesh Agarwal
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-04

Review 9.  Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.

Authors:  Justin N Bottsford-Miller; Robert L Coleman; Anil K Sood
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

Review 10.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.